Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide.↗
PeptideScanner retained ClinicalTrials.gov record NCT04219007 at 2026-07-30T16:22:22.347Z. Its registry update date was 2026-03-18, and PeptideScanner's reviewed identity mapping was vosoritide. 1
This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. 1
Exact identifier graph
This graph reports exact NCT and PMID identifiers declared in structured PubMed or ClinicalTrials.gov metadata for records already selected by PeptideScanner. A link or source reference type does not establish study quality, article findings, safety, effectiveness, regulatory approval, or a complete publication history.
Declared by both sources
PMID 38813446: Vosoritide treatment for children with hypochondroplasia: a phase 2 trial.
ClinicalTrials.gov reference type: DerivedComplete submitted registry timeline
ClinicalTrials.gov lists these public versions with submitted dates from January 2, 2020 through March 16, 2026. Each entry links to the exact public source version and reports only the source-declared status, study type, dates, and changed-module labels.
Source-declared changed modules: None listed for this version
Source-declared changed modules: Outcome Measures, Study Description, Study Status
Source-declared changed modules: Arms and Interventions, Conditions, Eligibility, Outcome Measures, Study Description, Study Identification, Study Status
Source-declared changed modules: Conditions, Contacts/Locations, Study Status
Source-declared changed modules: Study Status
Source-declared changed modules: Conditions, Eligibility, Study Status
Source-declared changed modules: Contacts/Locations, Study Design, Study Status
Source-declared changed modules: Contacts/Locations, Eligibility, Study Design, Study Status
Source-declared changed modules: Contacts/Locations, Study Design, Study Status
Source-declared changed modules: Study Status
ClinicalTrials.gov · Official source · Source checked August 8, 2026